论文部分内容阅读
胰腺外分泌功能检查对诊断某些胰腺疾病有重要意义。过去曾用的一些方法如Lu-ndh试验及P-S(促胰酶素/促胰液素)试验,需要插入十二指肠管收集胰液,方法繁琐,病人痛苦,临床上难以推广使用。1972年Imondi报道了口服BT-PABA(N-ben-zoyl-L-tyrosyl-P-aminobenzoic acid,N-苯甲酰-L-酪氨酰一对氨苯甲酸)检测胰腺功能不全动物获满意结果。Gyr及Ar-vantitakis先后应用于临床,嗣后国内外相继使用。我院自1982年起在临床上使用重庆医工所合成的BT-PABA(商品名胰功肽)开展这一检查,共260例。今将结果报道如下,并结合文献讨论其临床价值。
Pancreatic exocrine function test for the diagnosis of certain pancreatic diseases have important significance. Some methods used in the past, such as the Lu-ndh test and P-S (pancreensin / secretin) test, need to insert the duodenum to collect pancreatic juice, the cumbersome method, the patient suffering, difficult to promote the clinical use. In 1972, Imondi reported satisfactory results in the detection of pancreatic insufficiency using oral BT-PABA (N-benzoyl-L-tyrosyl-P-aminobenzoic acid) . Gyr and Ar-vantitakis have been used in clinical, subsequently used at home and abroad. Our hospital since 1982 in clinical use of Chongqing Medical synthesis of BT-PABA (pancreatic peptide) to carry out this test, a total of 260 cases. The results are reported below, and combined with the literature to discuss its clinical value.